Related references
Note: Only part of the references are listed.Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
Sunil Bhandari et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center
Laura Gobbi et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2020)
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
Iain C. Macdougall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up
Antonio Lacquaniti et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2020)
Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
Iain C. Macdougall et al.
CLINICAL NEPHROLOGY (2019)
Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy
Carla Rognoni et al.
ADVANCES IN THERAPY (2019)
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
Iain C. Macdougall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients
Li Wan et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
Jesse M. G. Hofman et al.
BMC NEPHROLOGY (2018)
Randomized trial of intravenous iron-induced hypophosphatemia
Myles Wolf et al.
JCI INSIGHT (2018)
Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients
Javier Deira et al.
RENAL FAILURE (2016)
Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
Matthew A. Roberts et al.
BMC Nephrology (2016)
A randomized, open-label trial of iron isomaltoside 1000 (MonoferA®) compared with iron sucrose (VenoferA®) as maintenance therapy in haemodialysis patients
Sunil Bhandari et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
A Randomized Comparison of Ferumoxytol and Iron Sucrose for Treating Iron Deficiency Anemia in Patients with CKD
Iain C. Macdougall et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Comparison of the Safety and Efficacy of 3 Iron Sucrose Iron Maintenance Regimens in Children, Adolescents, and Young Adults With CKD: A Randomized Controlled Trial
Stuart L. Goldstein et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
Myles Wolf et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study
Chaim Charytan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
Merche Prats et al.
BMC NEPHROLOGY (2013)
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
Peter Geisser et al.
Pharmaceutics (2011)
The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study
Adrian Covic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Clinical aspects of iron use in the anemia of kidney disease
Walter H. Hoerl
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography
S Beshara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Share Paper
